Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. 1993

P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
Division of Respiratory Medicine, University of Antwerp, Wilrijk, Belgium.

Pulmonary dysfunction caused by pulmonary neutrophil sequestration is a frequent postoperative complication in patients undergoing cardiopulmonary bypass (CPB) surgery. It is yet unclear whether treatment with corticosteroids in vivo in these patients can prevent complement-mediated neutrophil activation and sequestration in the lungs. Therefore, we conducted a prospective study in order to investigate whether methylprednisolone (MP) pretreatment (30 mg/kg) could influence the appearance of IL-8 (a recently discovered cytokine with potent neutrophil-chemotactic activity) in the peripheral circulation. We also studied the effects of MP pretreatment on the inflammatory parameters in the bronchoalveolar lavage (BAL) fluid 4 h postoperatively. Although peripheral neutropenia and the rise in IL-8 serum levels was less pronounced in MP-treated than in non-steroid-treated patients, there was no significant difference in albumin, total protein, concentrations of IL-8 and C3a, and the number of neutrophils in the BAL fluid between the two groups. However, when cultured in vitro, alveolar macrophages from patients treated with MP released significantly lower IL-8, both in basal conditions and after stimulation with lipopolysaccharide. Our results show that MP does not prevent (IL-8-mediated) pulmonary neutrophil infiltration after CPB, although it might affect certain aspects of the microvascular lung injury.

UI MeSH Term Description Entries
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
December 1989, The Journal of thoracic and cardiovascular surgery,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
January 1990, Pharmacotherapy,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
January 1999, Cytokine,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
October 1996, Anesthesia and analgesia,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
December 2019, CPT: pharmacometrics & systems pharmacology,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
October 1996, The Journal of thoracic and cardiovascular surgery,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
November 1993, Circulation,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
September 2015, Lancet (London, England),
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
February 1993, Journal of cardiothoracic and vascular anesthesia,
P G Jorens, and R De Jongh, and W De Backer, and J Van Damme, and F Van Overveld, and L Bossaert, and P Walter, and A G Herman, and M Rampart
January 1978, Circulatory shock,
Copied contents to your clipboard!